logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Münster University Hospital

+492518355555
epis-aki@ukmuenster.de
Source: Site record.
https://www.ukm.de

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Münster University Hospital is a premier, maximum-care academic medical center located at Albert-Schweitzer-Campus 1, 48149 Münster, Germany. Affiliated with the University of Münster, the facility operates over 1,500 beds and employs approximately 11,000 healthcare and research specialists, making it one of the largest medical hubs and regional employers in North Rhine-Westphalia. It treats over 60,000 inpatients and 500,000 outpatients annually.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. University hospital

Business Subcategory

Source: Human-provided. University hospital
Source: Human-provided. General hospital
Source: Trial-derived.
55Total Trials
Source: Trial-derived.
19Recruiting Trials
Source: Trial-derived.
26Active Trials
Source: Trial-derived.
0Completed Trials
Source: Trial-derived.
107Unique Conditions
Source: Trial-derived.
69Unique Sponsors

Conditions

Source: Trial-derived. Sepsis (6)Source: Trial-derived. Acute Kidney Injury (4)Source: Trial-derived. Inflammatory Bowel Diseases (3)Source: Trial-derived. Atopic Dermatitis (2)Source: Trial-derived. Microscopic Polyangiitis (2)Source: Trial-derived. Neoplasm Metastasis (2)Source: Trial-derived. Peripheral Arterial Disease (2)Source: Trial-derived. Septic Shock (2)

Sponsors

Source: Trial-derived. University Hospital Muenster (10)Source: Trial-derived. Universität Münster (5)Source: Trial-derived. Eli Lilly and Company (3)Source: Trial-derived. Boehringer Ingelheim (2)Source: Trial-derived. Guard Therapeutics AB (2)Source: Trial-derived. Janssen Research & Development, LLC (2)Source: Trial-derived. Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd (2)Source: Trial-derived. 41medical AG (1)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Vibration-controlled transient elastography (FibroScan)
Source: AI-inferred. MRI proton density fat fraction

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Timed pharmacokinetic sampling and processing

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Liver biopsy

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Enhanced liver fibrosis testing
Source: AI-inferred. Magnetic resonance elastography